NASDAQ:PRFX PainReform - PRFX News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PainReform Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. $0.69 +0.05 (+7.81%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.66▼$0.7050-Day Range$0.45▼$0.7652-Week Range$0.34▼$1.49Volume37,301 shsAverage Volume292,775 shsMarket Capitalization$7.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get PainReform News Delivered to You Automatically Sign up to receive the latest news and ratings for PRFX and its competitors with MarketBeat's FREE daily newsletter. Email Address PRFX Media Mentions By Week PRFX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRFX News Sentiment▼0.740.60▲Average Medical News Sentiment PRFX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRFX Articles This Week▼40▲PRFX Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePainReform Ltd: PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgeryfinanznachrichten.de - March 28 at 10:19 AMPainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgeryfinance.yahoo.com - March 28 at 10:19 AMPainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgeryfinance.yahoo.com - March 28 at 10:19 AMPainReform Ltd: PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomyfinanznachrichten.de - March 16 at 10:15 AMPainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomyfinance.yahoo.com - March 16 at 10:15 AMPainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomyfinance.yahoo.com - March 16 at 10:15 AMPainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgeryfinance.yahoo.com - March 14 at 9:36 AMPainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgeryfinance.yahoo.com - March 14 at 9:36 AMWhy Alteryx Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarketmsn.com - February 10 at 10:19 AMWhy Is PainReform (PRFX) Stock Up 48% Today?markets.businessinsider.com - February 8 at 9:58 AMPainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirementfinance.yahoo.com - February 7 at 6:52 PMPainReform Provides Business Update For Q3 2022; Ended The Quarter With ~$12.9M Cash And Deposits On Hand And No Debtbenzinga.com - November 15 at 11:48 PMPainReform Ltd: PainReform Provides Business Update for the Third Quarter of 2022finanznachrichten.de - November 15 at 1:47 PMPainReform Provides Business Update for the Third Quarter of 2022finance.yahoo.com - November 15 at 8:47 AMPainReform Provides Further Update on Manufacturing of PRF-110finance.yahoo.com - November 8 at 12:59 PMPainReform Provides PRF-110 Manufacturing Updatefinance.yahoo.com - October 4 at 10:40 AMPainReform to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 1 at 9:09 AMPainReform Announces Receipt of Nasdaq Minimum Bid Price Notificationfinance.yahoo.com - August 16 at 10:00 AMPainReform Provides Business Update for the Second Quarter of 2022finance.yahoo.com - August 16 at 10:00 AMPainReform Ltd. (PRFX)uk.finance.yahoo.com - July 16 at 12:10 AMPainReform Provides Business Update for the First Quarter of 2022 - GlobeNewswireglobenewswire.com - May 17 at 9:23 PMPainReform Provides Business Update for the First Quarter of 2022 - Yahoo Financefinance.yahoo.com - May 17 at 9:07 AMPainReform Provides Business Update for the First Quarter of 2022finance.yahoo.com - May 17 at 9:07 AMPainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th - Yahoo Financefinance.yahoo.com - April 14 at 10:37 PMPainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th - GlobeNewswireglobenewswire.com - April 12 at 12:03 PMPainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20thfinance.yahoo.com - April 12 at 12:03 PMPainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th - Yahoo Financefinance.yahoo.com - March 22 at 4:20 AMPainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th - GlobeNewswireglobenewswire.com - March 21 at 1:18 PMPainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30thfinance.yahoo.com - March 21 at 1:18 PMPainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022 - Yahoo Financefinance.yahoo.com - March 17 at 7:24 PMPainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022finance.yahoo.com - March 17 at 7:24 PMGlobal Postoperative Pain Pipeline Market Research Report 2022: Comprehensive Insights about 55+ Companies and 55+ Pipeline Drugs - ResearchAndMarkets.com - Business Wirebusinesswire.com - March 8 at 2:48 PMOverview Of Value Stocks In The Healthcare Sector - Benzinga - Benzingabenzinga.com - January 17 at 6:22 PMPre-market Movers: ONE, TSRI, BBLG, AHI, ACCD… - Nasdaqnasdaq.com - January 11 at 12:09 PMDelveInsight Examines a Robust Pipeline for Postoperative - GlobeNewswireglobenewswire.com - January 10 at 9:07 PMPainReform Ltd Shares Close the Day 13.8% Lower - Daily Wrapnasdaq.com - December 27 at 11:43 PMPainReform CEO to Participate in the Benzinga All Access Event on December 16thfinance.yahoo.com - December 14 at 9:32 AMTG Therapeutics, Krystal Biotech, BioXcel Therapeutics among major healthcare premarket losers' pack - Seeking Alphaseekingalpha.com - December 1 at 11:50 AMAUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today - Nasdaqnasdaq.com - November 24 at 9:46 AMRivian News: 12 Things for RIVN Stock Investors to Know About a Potential Deal With RV Rental Company Outdoorsy - Nasdaqnasdaq.com - November 24 at 9:46 AMShould You Investigate Perion Network Ltd. (NASDAQ:PERI) At US$25.68? - Nasdaqnasdaq.com - November 22 at 7:34 PMHow Many Professional Holding Corp. (NASDAQ:PFHD) Shares Do Institutions Own? - Nasdaqnasdaq.com - November 22 at 7:34 PMRivian News: 12 Things for RIVN Stock Investors to Know About a Potential Deal With RV Rental Company Outdoorsy - Investorplace.cominvestorplace.com - November 22 at 2:34 PMThese 4 Measures Indicate That PDC Energy (NASDAQ:PDCE) Is Using Debt Extensively - Nasdaqnasdaq.com - November 22 at 2:34 PMPRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today - InvestorPlaceinvestorplace.com - November 22 at 2:34 PMPRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Todayinvestorplace.com - November 22 at 1:02 PMWill PainReform (NASDAQ:PRFX) Spend Its Cash Wisely?finance.yahoo.com - November 22 at 9:33 AMPainReform Provides Business Update for the Third Quarter of 2021 - Yahoo Financefinance.yahoo.com - November 16 at 10:28 PMPainReform Provides Business Update for the Third Quarter of 2021 - GlobeNewswireglobenewswire.com - November 16 at 12:28 PMPainReform Provides Business Update for the Third Quarter of 2021finance.yahoo.com - November 16 at 12:28 PM Get PainReform News Delivered to You Automatically Sign up to receive the latest news and ratings for PRFX and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:PRFX) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.